Abstract
DQ-113 was compared in vitro to sitafloxacin, moxifloxacin, levofloxacin, and ciprofloxacin for potential to select mutational resistance in multiresistant staphylococci, pneumococci, and enterococci. Its ability to select less-susceptible mutants varied according to species, being lowest with staphylococci, intermediate with pneumococci, and greatest with enterococci.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Drug Resistance, Bacterial*
-
Drug Resistance, Microbial / genetics
-
Fluoroquinolones / pharmacology*
-
Gram-Positive Bacterial Infections / microbiology
-
Gram-Positive Cocci / drug effects*
-
Gram-Positive Cocci / genetics
-
Gram-Positive Cocci / isolation & purification
-
Microbial Sensitivity Tests
-
Quinolones / chemistry*
-
Quinolones / pharmacology*
Substances
-
DQ113
-
Fluoroquinolones
-
Quinolones